Establishment of a successful pregnancy requires not only implantation of a healthy embryo into a receptive uterus but also progesterone receptor (PGR)-dependent transformation of endometrial stromal cells (ESCs) into specialized decidual cells. Decidual cells support the developing embryo and are critical for placentation. We have previously shown that a known transcriptional coregulator of the PGR, steroid receptor coactivator-2 (SRC-2), is a critical driver of endometrial decidualization in both human and mouse endometrium. However, the full spectrum of genes transcriptionally controlled by SRC-2 in decidualizing ESCs has not been identified. Therefore, using an RNA-and chromatin immunoprecipitation-sequencing approach, we have identified the transcriptome of decidualizing human ESCs (hESCs) that requires SRC-2. We revealed that the majority of hESC genes regulated by SRC-2 are associated with decidualization. Over 50% of SRC-2-regulated genes are also controlled by the PGR. While ontology analysis showed that SRC-2-dependent genes are functionally linked to signaling processes known to underpin hESC decidualization, cell membrane processes were significantly enriched in this analysis. Follow-up studies showed that retinoid signaling is dependent on SRC-2 during hESC decidualization. Specifically, SRC-2 is required for full induction of the retinol transporter, stimulated by retinoic acid 6 (STRA6), which is essential for hESC decidualization. Together our findings show that a critical subset of genes transcriptionally reprogramed by PGR during hESC decidualization requires SRC-2. Among the multiple genes, pathways and networks that are dependent on SRC-2 during hESC decidualization, first-line analysis supports a critical role for this coregulator in maintaining retinoid signaling during progesterone-driven decidualization.
Introduction
For healthy couples, natural conception is remarkably inefficient with a success rate of only 30-40% per menstrual cycle (Wilcox et al. 1988 , Zinaman et al. 1996 , Macklon et al. 2002 . While 30% of these early pregnancy failures are linked to impaired embryo development, 70% are associated with a dysfunctional uterus during the periimplantation period (Macklon et al. 2002) . Periimplantation failure also compromises the full potential of assisted reproductive technologies, which rely on the transfer of healthy embryos into a receptive uterus (Blesa et al. 2014) . In addition to the clinical challenges, such early pregnancy losses impose severe emotional distress (Greil et al. 2010 ) and economic burdens on women and their families worldwide (Chambers et al. 2014) .
Formation of the decidua, through a process termed decidualization, is essential for advancement of the implantation process toward placentation (Cha et al. 2012) . Decidualization entails the rapid proliferation and differentiation of fibroblastic endometrial stromal cells into polygonal epithelioid decidual cells (Gellersen & Brosens 2014) . While modulating trophectodermal invasion into the maternal compartment that leads to placentation, the decidua also supports the developing embryo by providing histotrophic nutrition and local immunosuppression (Carson et al. 2000 , Gellersen et al. 2007 . Importantly, inadequate decidualization not only leads to fetal demise at an early stage of gestation but can potentially cause adverse pregnancy outcomes in subsequent trimesters (Wang & Dey 2006 , Norwitz et al. 2015 . Progesterone (P4), via its cognate nuclear receptor, the progesterone receptor (PGR), is essential for endometrial decidualization (Lydon et al. 1995) . Using genome-wide analysis, a number of studies have recently shown that PGR-mediated transcriptional reprogramming of human endometrial stromal cells (hESCs) underpins P4-dependent decidualization of this cell type (Cloke et al. 2008 , Mazur et al. 2015 . However, little is known concerning the involvement of the transcriptional coregulators that modulate PGR action during this cellular transformation process.
The p160/steroid receptor coactivator (SRC) family consists of three evolutionary conserved coregulators of transcription, termed SRC-1, -2 and -3 (Xu et al. 2009 ). First discovered as primary coregulators of nuclear receptor (NR)-mediated transcription, SRCs are now known to serve as pleiotropic transcriptional coregulators of a diverse range of non-NR transcription factors (Onate et al. 1995 , Voegel et al. 1996 , Torchia et al. 1997 , Xu et al. 2009 ). Because of the complex functional domain structure of SRCs, this coregulator class can integrate a myriad of signaling cues that control a broad spectrum of physiological and pathophysiological responses (Xu et al. 2009 , Stashi et al. 2014 . In the case of the uterus, we and others demonstrated that endometrial SRC-2 is required for early pregnancy establishment in the mouse (Gehin et al. 2002 , Mukherjee et al. 2006 . Using a conditional knockout mouse, we revealed that SRC-2 is indispensable for P4-dependent endometrial decidualization (Mukherjee et al. 2006) . Importantly from a clinical perspective, we also showed that SRC-2 is essential for P4-driven hESC decidualization in vitro (Kommagani et al. 2013) . Together, these studies underscored an evolutionary conserved role for SRC-2 in P4-dependent decidualization, a role not compensated by SRC-1 and/or SRC-3.
Given that P4-dependent hESC decidualization relies on transcriptional reprogramming and that SRC-2 as a transcriptional coregulator is critical for decidualization, we used RNA sequencing (RNA-seq) to identify the SRC-2-responsive transcriptome during this reprogramming event. To showcase the utility of this transcriptome dataset in elucidating new signaling connections with SRC-2 that are important for P4-dependent hESC decidualization, we reveal that full induction of stimulated by retinoic acid 6 (STRA6) expression is dependent on SRC-2 and required for hESC decidualization.
Materials and methods

Human subjects
Human protocols were prospectively approved by the Institutional Review Board at Baylor College of Medicine and were in accordance with the guidelines of the Declaration of Helsinki (WMA 1966) and written-informed consent was obtained from all participating subjects. Isolation of hESCs from endometrial tissue biopsied from women of reproductive age during the proliferative phase of their menstrual cycle has been described in Kommagani et al. (2016) .
Cell culture and siRNA transfection
Unless otherwise stated, cell culture media and reagents were purchased from Thermo Fisher Scientific. Human ESCs were maintained in DMEM/F12 medium containing 10% fetal bovine serum (FBS; Sigma-Aldrich), penicillin, streptomycin, an antimycotic, sodium bicarbonate and HEPES. Cells were transfected with siRNAs 48 h after plating into six-well plates at 8 × 10 4 cells per well. Following complexing of siRNAs with Lipofectamine RNAiMax (Thermo Fisher Scientific) in Opti-MEM I Reduced Serum Medium, cells were transfected with siRNAs at 60 pmol per well in MEM with 2% charcoal-stripped FBS (sFBS; Sigma-Aldrich).
In vitro decidualization
Following siRNA transfection, hESCs were decidualized with a hormone cocktail of 10 −8 M 17β-estradiol (E2), 10 −6 M medroxyprogesterone 17-acetate (MPA), and 5 × 10 −5 M N6,2′-O-dibutyryladenosine 3′,5′-cyclic monophosphate sodium salt (cAMP) (the hormone deciduogenic stimulus; termed EPC (Sigma-Aldrich)) in Opti-MEM I reduced serum medium with 2% sFBS. Cells were collected for RNA and/or protein isolation at day 0 and day 3 of EPC treatment.
RNA isolation and sequencing
Total RNA was prepared with the RNeasy Plus kit (Qiagen). For RNA sequencing, RNA purity and integrity was assessed using a NanoDrop spectrophotometer (Thermo Fisher Scientific) and an Agilent Bioanalyzer 2100 with Agilent RNA Nano 6000 chips, respectively. Sequencing of RNA was performed as described in Szwarc et al. (2018) . Briefly, libraries were prepared using TruSeq RNA library preparation kit v2 (Illumina, Inc.) and enriched by PCR. Adapter-ligated fragment concentration was measured by quantitative PCR assay with a KAPA library Quant kit (Kapabiosystems, Inc., Wilmington, MA, USA). Samples were then pooled and quantified again by qPCR. Bridge amplification using the cBot 2 system (Illumina, Inc.) was used for clonal cluster generation of library pools. Indexed paired-end sequencing was performed with the HiSeq 2500 sequencing system (Illumina, Inc.).
Analysis of RNA sequencing data
Raw reads of 101 nucleotides were trimmed by 11 nucleotides on their 5′ ends to increase mappability. The resulting 90-nucleotide pair-ended reads were mapped to the human genome (UCSC hg19) using STAR (Dobin et al. 2013 ) with NCBI RefSeq genes as the reference. Read duplicates were removed using picard tools (http://broadinstitute.github. io/picard/) in order to reduce possible PCR biases. HTseq (http://www-huber.embl.de/users/anders/HTSeq) was used to determine the number of reads falling within known genes (Liberzon et al. 2015) .
Chromatin immunoprecipitation followed by sequencing
Using a ChIP-grade antibody to human SRC-2 (Bethyl Laboratories, Montgomery, TX, USA; A300-346A), chromatin immunoprecipitation followed by sequencing (ChIP-seq) was performed as previously described on chromatin derived from hESCs treated with EPC for 3 days (Mazur et al. 2015 , Kommagani et al. 2016 .
Quantitative reverse transcriptase PCR
Reagents for quantitative reverse transcriptase PCR analysis were obtained from Applied Biosystems (AP) (Thermo Fisher Scientific). SuperScript VILO Master Mix was used to prepare cDNA according to the manufacturer's instructions. Resulting cDNAs of interest were quantified by real-time PCR using AP Biosystems QuantStudio 12K Flex Real-Time PCR System in reactions containing AP TaqMan Gene Expression Assays and AP TaqMan Universal Master Mix II. Taqman assays used in this study are listed in Supplementary Table 1 (see section on supplementary data given at the end of this article).
Protein isolation and Western blot
Protein was extracted from cells with NP40 buffer (150 mM NaCl, 1.0% NP-40, 50 mM Tris·Cl pH 8.0) with protease inhibitors (complete EDTA-free; Roche Diagnostics). Protein concentration was quantified using Pierce BCA Protein Assay Kit (Thermo Fisher Scientific). Protein (15-25 μg/lane) was resolved by SDS-PAGE (Biorad Laboratories) before transferring to a polyvinylidene fluoride membrane (Millipore). Nonspecific IgG binding was blocked with 5% milk in Tris-buffered saline with 0.1% Tween. Immunoreactive bands were detected with the following antibodies: STRA6 (Novus Biologicals, Littleton, CO; H00064220-D01P, diluted 1:1250), β-actin (Sigma-Aldrich; A1978, diluted 1:10,000). Secondary horse radish peroxidase-conjugated antibodies were purchased from Santa Cruz Biotechnology.
Statistical analysis
Results are presented as averages ± standard deviation. Statistical analysis was conducted in R Studio (R Studio Inc., Boston, MA, USA). Normality of data was examined on quantile comparison plots. Calculations of P values were performed with ANOVA with post hoc analysis performed with Tukey's range test; P > 0.05 were considered as non-significant differences while P ≤ 0.05 (*), P ≤ 0.01 (**) and P ≤ 0.001 (***) were considered significant.
Results
Identification of genes controlled by SRC-2 in hESCs during decidualization
To identify genes that are both important for hESC decidualization and transcriptionally dependent on SRC-2, RNA-seq was performed on the following hESC RNA samples in triplicate: (1) cells transfected with NT siRNA collected at day 0 of EPC treatment (NT siRNA day 0 EPC); (2) cells transfected with SRC-2 siRNA collected at day 0 of EPC treatment (SRC-2 siRNA day 0 EPC); (3) cells transfected with NT siRNA collected at day 3 of EPC treatment (NT siRNA day 3 EPC) and (4) cells transfected with SRC-2 siRNA collected at day 3 of EPC treatment (SRC-2 siRNA day 3 EPC). Principal component analysis (Supplementary Fig. 1A and B) revealed that individual experimental samples were primarily grouping based on the time-point of EPC treatment (day 0 and 3 of EPC treatment). From the resultant RNA-seq data, paired comparisons were performed to reveal the following gene expression changes: (1) NT siRNA day 3 EPC vs NT siRNA day 0 EPC: to reveal gene expression changes which occur during decidualization; (2) SRC-2 siRNA day 0 EPC vs NT siRNA day 0 EPC: to detect gene expression affected by SRC-2 knockdown before the onset of decidualization and (3) SRC-2 siRNA day 3 EPC vs NT siRNA day 3 EPC: to identify gene expression changes caused by SRC-2 knockdown at day 3 of EPC (decidualization). After applying analytical cut-offs of |FC| ≥1.5 and FDR <0.05, the expression of over 5552 RefSeq genes was found to be significantly altered during decidualization ( Fig. 1A ; NT siRNA day 3 EPC vs NT siRNA day 0 EPC). The number of genes and the degree of gene expression changes with day 3 EPC (decidualization) treatment are in agreement with our previously published decidual control dataset (Szwarc et al. 2018) , which served as a quality control for our current study ( Supplementary Fig. 1C ). The full list of gene expression changes in all three datasets is found in Supplementary data 1. Knockdown of SRC-2 caused significant changes in expression of 385 and 326 genes at day 0 and day 3 of EPC treatment, respectively (Fig. 1A) . Over half of the genes transcriptionally regulated by SRC-2 are also induced or repressed during EPC-induced decidualization. While the most robust changes in gene expression occur during decidualization with |FCs| reaching as high as 8400, SRC-2 knockdown leads to gene expression changes found primarily in the −5 to +5 fold change (FC) range (Fig. 1B and Supplementary Fig. 2 ). The analysis of the expression changes of genes altered by both the EPC treatment (comparison 1 as shown in Fig. 1A ) and the SRC-2 knockdown at either day 0 of EPC treatment (comparison 2, Fig. 1A ) or day 3 of EPC treatment (comparison 3, Fig. 1A ) revealed a very distinct pattern of expression change directionality. The majority of expression changes of genes altered both by knockdown of SRC-2 at day 3 of EPC treatment (comparison 3) and by EPC treatment (comparison 1) occurred in the opposite direction (i.e. if a gene was upregulated in comparison 1, it would be downregulated in comparison 3 and vice versa) (Supplementary Fig. 3B ). Conversely, SRC-2 knockdown at day 0 of EPC treatment (comparison 2) caused gene expression changes primarily in the same direction as occurs during decidualization (comparison 1) (Supplementary Fig. 3A) .
As a first-line validation analysis to confirm the hESC gene expression changes due to SRC-2 knockdown as shown in the volcano plot (Fig. 1B) , we used quantitative reverse transcriptase PCR analysis on an arbitrary chosen set of genes (Fig. 1C) . As expected, SRC-2 knockdown resulted in the upregulation or downregulation of the following genes: ATP-binding cassette subfamily A member 6 (ABCA6), ABCA9, ADAM metallopeptidase with thrombospondin type 1 motif 15 (ADAMTS15), aldehyde dehydrogenase 1 family member A3 (ALDH1A3), cannabinoid receptor 1 (CNR1) and scavenger receptor class A member 5 (SCARA5).
Collectively, these results demonstrate that SRC-2 exerts potent coregulator control of genome-wide transcriptional reprogramming that occurs when hESCs undergo decidualization. These results provide a much needed molecular perspective to our previous studies, which demonstrated a critical functional role for this coactivator in hESC and murine uterine decidualization (Mukherjee et al. 2006 , Kommagani et al. 2013 .
Gene expression changes dependent on SRC-2 regulate cellular processes associated with hESC decidualization
To reveal the cellular and molecular processes controlled by SRC-2 at day 0 EPC and day 3 of EPC (the 385 and 326 genes altered by SRC-2 knockdown respectively as presented in Fig. 1A ), Gene Ontology (GO) analysis with the DAVID Functional Annotation Clustering tool (Fig. 2) and Gene Set Enrichment Analysis (GSEA) ( Supplementary Fig. 4) were performed. Bioinformatic analysis revealed that SRC-2 is primarily linked to the regulation of gene expression associated with cell membrane signaling and transport. Importantly, a subset of the molecular pathways and terms found to be enriched with SRC-2 knockdown have been previously implicated in the execution of the decidual progression program, such as extracellular matrix remodeling, immunomodulation and cell cycle regulation (Gellersen & Brosens 2014) .
Expression of a subset of genes dependent on PGR requires SRC-2
To identify genes that are regulated during hESC decidualization by both SRC-2 and PGR, we integrated the lists of genes that are upregulated or downregulated when SRC-2 or PGR (Mazur et al. 2015) are knocked down at day 3 of EPC treatment. Although the number of hESC genes controlled by PGR is significantly Figure 1 Global gene expression changes that occur during hESC decidualization and with SRC-2 knockdown. (A) Venn diagram displaying the numbers of genes identified by RNA-seq for which expression is significantly changed (|FC| ≥1.5, FDR <0.05) by: (1) decidualization; (2) by SRC-2 knockdown before the onset of decidualization or (3) by SRC-2 knockdown at day 3 of decidualization/EPC treatment. These data also include the number of overlapping and non-overlapping genes between these three datasets. (B) Volcano plot of the FC and −log10 P-value of gene expression changes detected by RNA-seq as presented in (A). For clarity, |FC| cut-off has been set at 50. Genes with the highest |FC| >100 are represented in Supplementary Fig. 2 . All data can be found in Supplementary data 1. (C) Quantitative reverse transcriptase PCR analysis of a select number of genes (highlighted in (B)) that confirms the gene expression changes identified by RNA-seq profiling.
greater than the number regulated by SRC-2 at day 3 EPC treatment (2503 vs. 326 genes), almost 55% of the SRC-2 regulated genes (178 out of 326) are also regulated by PGR (Fig. 3A) . Following DAVID functional annotation clustering analysis of genes that are (1) only regulated by SRC-2 (148 genes); (2) only regulated by PGR (2325 genes) or (3) regulated by both SRC-2 and PGR (178 genes), we found the overlap between SRC-2 and PGR altered genes was significantly enriched for genes involved in 'hormone activity/female pregnancy' ( Fig. 3B ; middle column (highlighted)). Validation of gene expression changes by qPCR (Fig. 3C ) confirmed that these genes -adrenomedullin (ADM), chorionic gonadotropin alpha polypeptide (CGA), insulin like growth factor 1 (IGF1), parathyroid hormone like hormone (PTHLH), prolactin (PRL) and urocortin 2 (UCN2) -were not only upregualted or downregulated following SRC-2 knockdown, but the expression of these genes is significantly changed during hESC decidualization (Fig. 3C) .
Induction of retinol transporters essential for hESC decidualization requires SRC-2
Integrating genes regulated by SRC-2 and PGR with gene expression changes resulting from EPC treatment for 3 days revealed that 89% of genes controlled by both SRC-2 and PGR are also responsive to EPC treatment (Fig. 4A) . Moreover, integration of this RNA-seq dataset with a previously published ChIP-seq dataset for PGR (Mazur et al. 2015) and our ChIP-seq dataset for SRC-2 showed that from the 153 potential gene targets of SRC-2, PGR and EPC, 16 of these target genes are directly bound by both SRC-2 and PGR within 25 kb of the gene (Fig. 4B) . Interestingly, one of these target genes is stimulated by retinoic acid 6 (STRA6; Fig. 3B ), which is bound by both SRC-2 and PGR on its proximal promoter region (Fig. 4C) . During hESC decidualization (day 3 vs day 0 EPC treatment), STRA6 transcript levels are significantly increased, and this transcriptional induction is severely attenuated when SRC-2 levels are reduced (Fig. 4D) . Apart from STRA6, we also showed that SRC-2 indirectly controls the induction of another important component of retinoid trafficking, retinolbinding protein 4 (RBP4) (Fig. 4E) . Importantly, reduction of STRA6 protein levels ( Supplementary Fig. 5 ) leads to a significant reduction in the induction of IGFBP1 and PRL (Fig. 4F) , which are established molecular biomarkers of decidualization (Brosens et al. 1999) . Together, our data reveal for the first time a signaling connection between SRC-2 and retinoid transport, which is required for full hESC decidualization.
Discussion
Notwithstanding the significant advances in delineating the pivotal effector signals that are critical for progesterone-dependent hESC decidualization, our knowledge of the key endometrial coregulators involved in these signaling processes remains incomplete. Using an advanced engineered mouse model, we previously demonstrated that SRC-2 abrogation results in a block in progesterone-driven endometrial decidualization, which results in pregnancy failure (Mukherjee et al. 2006 , Mukherjee et al. 2007 . Interestingly, forced SRC-2 overexpression in the murine uterus also blocks endometrial decidualization (Szwarc et al. 2014a) , suggesting that critical controls on SRC-2 levels are necessary to maintain normal endometrial cell function (Szwarc et al. 2014b) . Important from a clinical perspective, we demonstrated that SRC-2 is expressed in human endometrial tissue and essential for hESC decidualization in vitro (Mukherjee et al. 2007 , Kommagani et al. 2013 , providing critical translational support for observations made in the mouse. Because of the established role of SRC-2 as a pleiotropic coregulator of metabolism in other physiological systems (Stashi et al. 2014) , we initially employed metabolomic profiling to gain a firsthand mechanistic understanding of SRC-2's role in hESC decidualization (Kommagani et al. 2013) . This profiling method furnished essential metabolic insight into SRC-2's role in hESC decidualization; however, SRC-2's involvement in global transcriptional reprogramming that is known to occur with progesterone-driven decidualization could not be addressed by this approach. Therefore, to annotate the genome-wide transcriptional responses that are modulated by SRC-2 during progesterone-dependent hESC decidualization, we used here a primary cell culture model, siRNA-mediated knockdown approaches and RNA-seq and ChIP-seq technologies followed by bioinformatic analysis and validation. With an integrative analytic strategy, we found that approximately 50% of genes regulated by SRC-2 are also controlled by PGR; underscoring SRC-2's dedicated coregulator role in PGR-mediated signaling during hESC decidualization. In keeping with its pleiotropic coregulator role, SRC-2 regulates a broad spectrum of target genes during hESC decidualization, many of which encode cell membrane-associated proteins. Importantly, functional gene enrichment analysis demonstrated a significant representation of genes regulated by SRC-2 along with PGR involved in the 'hormone activity/ reproduction/pregnancy' category. Integration of RNAand ChIP-seq datasets further stratified this category of genes in terms of direct targets of both PGR and SRC-2 to reveal STRA6 as a gene target directly regulated by this NR and coregulator.
This finding is significant as STRA6 is an integral cell membrane protein that transports retinol into the cell for conversion into retinoic acid, which in turn acts as the ligand for retinoic acid receptor subtypes (Leid et al. 1993) . Even though Stra6 knockout mice are fertile (Berry et al. 2013) , the functional importance of STRA6 is strikingly different between human and rodent. In humans, STRA6 mutations leading to Matthew-Woods syndrome cause devastating phenotypes in human not seen in the mouse knockout, underscoring the functional divergence of STRA6 between human and rodent (Golzio et al. 2007 , Pasutto et al. 2007 . Retinoid signaling is known to control cell differentiation, proliferation and cell survival in numerous physiological and pathological contexts (Jiang et al. 2018) . In the case of the endometrial stromal cell, a number of studies have shown that retinoid transport, metabolism and activity are essential for normal cellular function and that the observed perturbation of retinoid signaling in endometriotic cells may explain the decreased ability of these cells to decidualize (Pavone et al. 2011 , Pierzchalski et al. 2014 . In particular, STRA6 expression levels, previously shown to be dependent on PGR and responsible for retinoic acid transport in normal hESCs (Pavone et al. 2010) , are strikingly reduced in endometriotic cells (Pavone et al. 2011) . Our studies also show that the normal induction of RBP4 expression during hESC decidualization is critically dependent on SRC-2. Compared to hESCs, levels of RBP4 have also been shown to be severely reduced in endometriotic stromal cells (Pavone et al. 2017) . Interestingly, other studies have demonstrated that RBP4 acts as a paracrine factor when induced and secreted from hESCs during decidualization (Pavone et al. 2017) . Secreted from hESCs, RBP4 is thought to act on adjacent epithelial cells to stimulate conversion of estradiol to estrone (Cheng et al. 2007) , thereby reducing estradiol levels that can be detrimental to normal endometrial growth homeostasis and function (Cha et al. 2012) . Apart from uncovering a novel convergence of SRC2, PGR and retinoid signaling that is critical for hESC decidualization, two important questions emerge for future investigation:
(1) what other transcription factors (NR and/or non-NR) -apart from PGR -interact with SRC-2 to control the hESC transcriptome during decidualization? And (2) what is the makeup of the transcriptional interactome that enables SRC-2 to modulate transcriptional responses in decidualizing hESCs?
In sum, transcriptomic analysis described herein provides a much required global molecular perspective on SRC-2's critical role in progesterone-dependent hESC decidualization and represents a powerful informational resource with which to uncover novel signaling paradigms for SRC-2 action in uterine function.
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